We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




AI Tool Accurately Identifies Pediatric Patients at High Risk for Blood Clots

By HospiMedica International staff writers
Posted on 31 Oct 2023
Print article
Image: The new AI tool can accurately identify pediatric patients at high risk for blood clots (Photo courtesy of 123RF)
Image: The new AI tool can accurately identify pediatric patients at high risk for blood clots (Photo courtesy of 123RF)

Blood clots in children are uncommon but can extend hospital stays and elevate the risks of complications and mortality after discharge. A new artificial intelligence (AI) tool is now available to accurately identify which pediatric patients are at high risk for developing blood clots.

Researchers conducting a clinical trial called CLOT, led by Vanderbilt University Medical Center (VUMC, Nashville, TN, USA), found the AI tool to be effective in identifying pediatric patients at a higher risk for blood clots. However, the outcomes didn't differ from the control group. This was partly because physicians accepted the AI's recommendation to start blood-thinning treatment in less than 26% of the high-risk cases. Doctors had concerns that the treatment might lead to significant bleeding, even though such complications were not noted during the study. Despite the unexpected results, the research confirmed the AI tool's safety and efficacy and offered key insights for its successful integration into healthcare practice.

To determine who was at higher risk, the research team examined over 110,000 admissions to a children's hospital from electronic medical records. They found 11 factors linked to a greater risk of blood clots, like specific lab results, diagnoses, and whether the patient had surgery or consultations with cardiology or infectious diseases. This data was used to create a predictive model that calculated daily risk scores for every child admitted to the hospital, enabling the team to rapidly assess more than 100 patients each day and zero in on those most likely to develop blood clots.

The 15-month trial, spanning from November 2020 to January 2022, included 17,000 hospital stays and had patients randomly assigned to two groups. For the study group, their risk scores and anti-clotting treatment recommendations were shared with their medical teams. The control group patients were deemed high risk by their doctors without the aid of the AI tool, and they also received blood-thinning medications. Neither group experienced bleeding complications from the treatment. Ultimately, the rate of blood clots did not differ between the two groups, and it was found that the recommendation to begin blood-thinning therapy was followed just 25.8% of the time in the study group.

The CLOT trial showed that it is possible to quickly get results without straining the medical team's time or resources, simply by using existing electronic medical record data to automatically include patients in clinical trials. It also proved that AI models have potential value in healthcare. However, there are still challenges to address. Future trials are being planned to delve into why healthcare providers are hesitant to follow AI recommendations for blood-thinning treatments in high-risk cases and how to overcome that reluctance.

“There is going to be more and more AI in healthcare. Having a system established where we can assess these (models) will allow us to provide safer and more effective care to our patients,” said Shannon Walker, MD.

“This study demonstrates that a pragmatic patient-level, randomized, controlled trial is the most ethical and effective way to assess whether AI tools are safe and effective,” added Daniel Byrne, MS.

Related Links:
VUMC 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
24.5-inch Full HD 2D OLED Medical Monitor
PVM-2551MD

Print article

Channels

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.